Active Ingredient
Oxymetazoline hydrochloride 0.05%
The following Structured Product Label (SPL) was submitted to the FDA by Cadila Healthcare Limited for the product Oxymetazoline Hydrochloride (NDC 65841-711). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, when using this product, other, keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Oxymetazoline hydrochloride 0.05%
Nasal decongestant
■ a cold ■ hay fever ■ upper respiratory allergies
Ask a doctor before use if you have
■ heart disease ■ high blood pressure ■ thyroid disease ■ diabetes
■ trouble urinating due to an enlarged prostate gland
Stop use and ask a doctor if symptoms persist.
If pregnant or breast-feeding, ask a health professional before use.
Manufactured by:
Cadila Healthcare Ltd.
Ahmedabad, India
Rev.: 00/00
Revision Date: 05/31/2011
If swallowed, get medical help or contact a Poison Control Center right away.
2 or 3 sprays in each nostril not more than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
Shake well before use. Before using the first time, remove the protective cap from the tip and prime metered pump by depressing firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress pump all the way down with a firm even stroke and sniff deeply. Wipe nozzle clean after use.
benzalkonium chloride solution, camphor, edetate disodium, eucalyptol, glycin, menthol, polyethylene glycol, polysorbate 80, propylene glycol, purified water, sodium chloride, sodium hydroxide.
* Please review the disclaimer below.